- Home
- CASK vs ADTX Comparison
CASK vs ADTX Comparison
Compare CASK & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASK
- ADTX
- Stock Information
- Founded
- CASK 2011
- ADTX 2017
- Country
- CASK United States
- ADTX United States
- Employees
- CASK N/A
- ADTX N/A
- Industry
- CASK
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- CASK
- ADTX Health Care
- Exchange
- CASK NYSE
- ADTX Nasdaq
- Market Cap
- CASK 6.5M
- ADTX 5.3M
- IPO Year
- CASK 2024
- ADTX 2020
- Fundamental
- Price
- CASK $0.61
- ADTX $2.30
- Analyst Decision
- CASK
- ADTX
- Analyst Count
- CASK 0
- ADTX 0
- Target Price
- CASK N/A
- ADTX N/A
- AVG Volume (30 Days)
- CASK 123.3K
- ADTX 595.9K
- Earning Date
- CASK 05-25-2025
- ADTX 05-19-2025
- Dividend Yield
- CASK N/A
- ADTX N/A
- EPS Growth
- CASK N/A
- ADTX N/A
- EPS
- CASK N/A
- ADTX N/A
- Revenue
- CASK $7,522,832.00
- ADTX $133,985.00
- Revenue This Year
- CASK N/A
- ADTX $15,768.94
- Revenue Next Year
- CASK N/A
- ADTX N/A
- P/E Ratio
- CASK $23.41
- ADTX N/A
- Revenue Growth
- CASK N/A
- ADTX N/A
- 52 Week Low
- CASK $0.40
- ADTX $2.04
- 52 Week High
- CASK $4.00
- ADTX $27,200.00
- Technical
- Relative Strength Index (RSI)
- CASK N/A
- ADTX 30.49
- Support Level
- CASK N/A
- ADTX $2.04
- Resistance Level
- CASK N/A
- ADTX $2.39
- Average True Range (ATR)
- CASK 0.00
- ADTX 0.45
- MACD
- CASK 0.00
- ADTX 0.48
- Stochastic Oscillator
- CASK 0.00
- ADTX 7.54
About CASK HERITAGE DISTILLING HOLDING COMPANY INC
Heritage Distilling Holding Co Inc is a craft distiller producing, marketing and selling a diverse line of award-winning craft spirits, including whiskeys, vodkas, gins, rums, and ready-to-drink canned cocktails. The company sells its products through wholesale distribution, directly to consumers through its owned and operated distilleries and tasting rooms located in Washington and Oregon and by shipping directly to consumers online where legal. Currently, It sells products primarily in the Pacific Northwest with limited distribution in other states throughout the U.S.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.